Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cannabidiol and cardiovascular:

Cannabidiol: State of the art and new challenges for therapeutic applications. Pisanti S et al. Pharmacol Ther. (2017)

Cardiovascular Complications of Marijuana and Related Substances: A Review. Singh A et al. Cardiol Ther. (2018)

Medical Marijuana: Just the Beginning of a Long, Strange Trip? Ciccone CD et al. Phys Ther. (2017)

Search results

Items: 1 to 20 of 106

1.

Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer.

Pellati F, Borgonetti V, Brighenti V, Biagi M, Benvenuti S, Corsi L.

Biomed Res Int. 2018 Dec 4;2018:1691428. doi: 10.1155/2018/1691428. eCollection 2018. Review.

2.

Cannabis-based products for pediatric epilepsy: A systematic review.

Elliott J, DeJean D, Clifford T, Coyle D, Potter BK, Skidmore B, Alexander C, Repetski AE, Shukla V, McCoy B, Wells GA.

Epilepsia. 2019 Jan;60(1):6-19. doi: 10.1111/epi.14608. Epub 2018 Dec 4.

PMID:
30515765
3.

Up-regulation of heme oxygenase-1 expression and inhibition of disease-associated features by cannabidiol in vascular smooth muscle cells.

Schwartz M, Böckmann S, Hinz B.

Oncotarget. 2018 Oct 2;9(77):34595-34616. doi: 10.18632/oncotarget.26191. eCollection 2018 Oct 2.

4.

Cannabis for pediatric epilepsy: protocol for a living systematic review.

Elliott J, DeJean D, Clifford T, Coyle D, Potter B, Skidmore B, Alexander C, Repetski AE, McCoy B, Wells GA.

Syst Rev. 2018 Jul 18;7(1):95. doi: 10.1186/s13643-018-0761-2. Review.

5.

The pharmacokinetics and the pharmacodynamics of cannabinoids.

Lucas CJ, Galettis P, Schneider J.

Br J Clin Pharmacol. 2018 Nov;84(11):2477-2482. doi: 10.1111/bcp.13710. Epub 2018 Aug 7. Review.

PMID:
30001569
6.

Cross-talk of cannabinoid and endocannabinoid metabolism is mediated via human cardiac CYP2J2.

Arnold WR, Weigle AT, Das A.

J Inorg Biochem. 2018 Jul;184:88-99. doi: 10.1016/j.jinorgbio.2018.03.016. Epub 2018 Apr 7.

PMID:
29689453
7.

The quest for endothelial atypical cannabinoid receptor: BKCa channels act as cellular sensors for cannabinoids in in vitro and in situ endothelial cells.

Bondarenko AI, Panasiuk O, Drachuk K, Montecucco F, Brandt KJ, Mach F.

Vascul Pharmacol. 2018 Mar;102:44-55. doi: 10.1016/j.vph.2018.01.004. Epub 2018 Jan 31.

PMID:
29355732
8.

Abnormal cannabidiol confers cardioprotection in diabetic rats independent of glycemic control.

Matouk AI, Taye A, El-Moselhy MA, Heeba GH, Abdel-Rahman AA.

Eur J Pharmacol. 2018 Feb 5;820:256-264. doi: 10.1016/j.ejphar.2017.12.039. Epub 2017 Dec 20.

9.

Cardiovascular Complications of Marijuana and Related Substances: A Review.

Singh A, Saluja S, Kumar A, Agrawal S, Thind M, Nanda S, Shirani J.

Cardiol Ther. 2018 Jun;7(1):45-59. doi: 10.1007/s40119-017-0102-x. Epub 2017 Dec 7. Review.

10.

Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention.

Scharf EL.

Cannabis Cannabinoid Res. 2017 Oct 1;2(1):259-264. doi: 10.1089/can.2017.0033. eCollection 2017. Review.

11.

Human podocytes express functional thermosensitive TRPV channels.

Ambrus L, Kelemen B, Szabó T, Bíró T, Tóth BI.

Br J Pharmacol. 2017 Dec;174(23):4493-4507. doi: 10.1111/bph.14052. Epub 2017 Nov 2.

12.

Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury.

Wang Y, Mukhopadhyay P, Cao Z, Wang H, Feng D, Haskó G, Mechoulam R, Gao B, Pacher P.

Sci Rep. 2017 Sep 21;7(1):12064. doi: 10.1038/s41598-017-10924-8.

13.

A randomised controlled cross-over double-blind pilot study protocol on THC:CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity.

Marinelli L, Balestrino M, Mori L, Puce L, Rosa GM, Giorello L, Currà A, Fattapposta F, Serrati C, Gandolfo C, Abbruzzese G, Trompetto C.

BMJ Open. 2017 Sep 7;7(9):e016843. doi: 10.1136/bmjopen-2017-016843.

14.

Intra-cerebral cannabidiol infusion-induced neuroprotection is partly associated with the TNF-α/TNFR1/NF-кB pathway in transient focal cerebral ischaemia.

Khaksar S, Bigdeli MR.

Brain Inj. 2017;31(13-14):1932-1943. doi: 10.1080/02699052.2017.1358397. Epub 2017 Sep 5.

PMID:
28872345
15.

A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study.

Jadoon KA, Tan GD, O'Sullivan SE.

JCI Insight. 2017 Jun 15;2(12). pii: 93760. doi: 10.1172/jci.insight.93760. [Epub ahead of print]

16.

In Vivo Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats.

Wheal AJ, Jadoon K, Randall MD, O'Sullivan SE.

Front Pharmacol. 2017 May 18;8:248. doi: 10.3389/fphar.2017.00248. eCollection 2017.

17.

A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol.

Sultan SR, Millar SA, England TJ, O'Sullivan SE.

Front Pharmacol. 2017 Feb 24;8:81. doi: 10.3389/fphar.2017.00081. eCollection 2017.

18.

Strokes are possible complications of cannabinoids use.

Wolff V, Jouanjus E.

Epilepsy Behav. 2017 May;70(Pt B):355-363. doi: 10.1016/j.yebeh.2017.01.031. Epub 2017 Feb 23. Review.

PMID:
28237318
19.

Cannabidiol: State of the art and new challenges for therapeutic applications.

Pisanti S, Malfitano AM, Ciaglia E, Lamberti A, Ranieri R, Cuomo G, Abate M, Faggiana G, Proto MC, Fiore D, Laezza C, Bifulco M.

Pharmacol Ther. 2017 Jul;175:133-150. doi: 10.1016/j.pharmthera.2017.02.041. Epub 2017 Feb 22. Review.

PMID:
28232276
20.

Anti-excitotoxic effects of cannabidiol are partly mediated by enhancement of NCX2 and NCX3 expression in animal model of cerebral ischemia.

Khaksar S, Bigdeli MR.

Eur J Pharmacol. 2017 Jan 5;794:270-279. doi: 10.1016/j.ejphar.2016.11.011. Epub 2016 Nov 14.

PMID:
27856160

Supplemental Content

Loading ...
Support Center